The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies
Abstract
Summary: The prevalence of hepatitis B virus (HBV) infection in patients with haematological malignancies is increased compared with the general population worldwide. HBV reactivation is common following chemotherapy and is associated with a high mortality despite prompt anti‐viral treatment. HBV reactivation may necessitate interruption of chemotherapy with adverse prognostic consequences for the haematological disease. Chemotherapy‐induced immune suppression may lead to increased HBV replication. Immune reconstitution within the weeks and months following recovery from chemotherapy may be associated with a flare of hepatitis B manifested by hepatocellular injury. Risk factors associated with HBV reactivation include detectable hepatitis B surface antigen (HBsAg), HBV DNA, Hepatitis B e (HBeAg) antigen, antibodies to hepatitis B core antigen (anti‐HBc), treatment with corticosteroids, young age and male gender. Lamivudine is effective during HBV reactivation due to immune suppression. Clinical trials have demonstrated that pre‐emptive antiviral treatment with lamivudine is superior to deferred treatment. Current recommendations emphasise screening for HBV infection in all haematology patients, particularly prior to chemotherapy. Patients who are HBsAg positive or HBV DNA positive should receive pre‐emptive treatment with lamivudine before chemotherapy. The duration of lamivudine treatment may be prolonged commensurate with the degree of immunosuppression. HBV naïve patients should be immunised against hepatitis B, as should haematopoietic stem cell donors. In summary, overt and occult HBV pose a serious, but preventable, threat. Pre‐treatment screening of patients at risk should be practiced diligently by all clinicians that treat patients with malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
Lavanchy, D. (2004) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00487.x · Cited by 2,642
A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B
Chang, T.-T., Gish, R. G., de Man, R., Gadano, A., Sollano, J., Chao, Y.-C., Lok, A. S., Han, K.-H., Goodman, Z., Zhu, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051285 · Cited by 1,444
Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B
Lai, C.-L., Shouval, D., Lok, A. S., Chang, T.-T., Cheinquer, H., Goodman, Z., DeHertogh, D., Wilber, R., Zink, R. C., Cross, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051287 · Cited by 1,188
Self-citationHepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B
Kao, J., Chen, P., Lai, M., & Chen, D. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70261-7 · Cited by 925
Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy
Lok, A. S. F., Liang, R. H. S., Chiu, E. K. W., Wong, K.-L., Chan, T.-K., & Todd, D. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90599-g · Cited by 827
Yeo, W., Chan, P. K. S., Zhong, S., Ho, W. M., Steinberg, J. L., Tam, J. S., Hui, P., Leung, N. W. Y., Zee, B., & Johnson, P. J. (2000) · Journal of Medical Virology · doi:10.1002/1096-9071(200011)62:3<299::aid-jmv1>3.0.co;2-0 · Cited by 627
Yim, H. J., & Lok, A. S.-F. (2006) · Hepatology · doi:10.1002/hep.20956 · Cited by 545
Molecular Virology of Hepatitis B Virus
Locarnini, S. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-828672 · Cited by 515
Osterborg, A., Dyer, M. J., Bunjes, D., Pangalis, G. A., Bastion, Y., Catovsky, D., & Mellstedt, H. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1567 · Cited by 512
Shouval, D. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00152-1 · Cited by 470
Self-citationLau, G. K. K., Yiu, H. H. Y., Fong, D. Y. T., Cheng, H.-C., Au, W.-Y., Lai, L. S. F., Cheung, M., Zhang, H.-Y., Lie, A., Ngan, R., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.026 · Cited by 458
Epidemiology and Natural History of Hepatitis B
McMahon, B. J. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-915644 · Cited by 454
Hui, C., Cheung, W. W. W., Zhang, H., Au, W., Yueng, Y., Leung, A. Y. H., Leung, N., Luk, J. M., Lie, A. K. W., Kwong, Y., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.015 · Cited by 453
Perrillo, R. P. (2001) · Gastroenterology · doi:10.1053/gast.2001.22461 · Cited by 421
David, S., & Hamilton, J. P. (2010) · PubMed · Cited by 399
Hepatitis B virus DNA contains a glucocorticoid-responsive element.
Tur-Kaspa, R., Burk, R. D., Shaul, Y., & Shafritz, D. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1627 · Cited by 389
The immune response during hepatitis B virus infection
Bertoletti, A., & Gehring, A. J. (2006) · Journal of General Virology · doi:10.1099/vir.0.81920-0 · Cited by 385
Cytotoxic T cells and viral hepatitis.
Chisari, F. V. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119308 · Cited by 367
Lok, A. S. F., Lai, C.-L., Wu, P.-C., Leung, E. K. Y., & Lam, T.-S. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90613-5 · Cited by 326
Yeo, W., Zee, B., Zhong, S., Chan, P. K. S., Wong, W.-L., Ho, W. M., Lam, K. C., & Johnson, P. J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601699 · Cited by 312
Cheng, A., Hsiung, C. A., Su, I., Chen, P., Chang, M., Tsao, C.-J., Kao, W.-Y., Uen, W., Hsu, C., Tien, H., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50220 · Cited by 289
Rituximab treatment results in impaired secondary humoral immune responsiveness
van der Kolk, L. E., Baars, J. W., Prins, M. H., & van Oers, M. H. J. (2002) · Blood · doi:10.1182/blood.v100.6.2257 · Cited by 284
Yeo, W., Chan, P. K. S., Ho, W. M., Zee, B. C.-Y., Lam, K. C., Lei, K. I. K., Chan, A. T. �., Mok, T. S. K., Lee, J. J., Leung, T. W. H., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.161 · Cited by 259
Wands, J. R., Chura, C. M., Roll, F. J., & Maddrey, W. C. (1975) · Gastroenterology · doi:10.1016/s0016-5085(75)80054-0 · Cited by 253
A controlled trial of interferon with or without prednisone priming for chronic hepatitis B
Lok, A. S. F., Wu, P.-C., Lai, C.-L., Lau, J. Y. N., Leung, E. K. Y., Wong, L. S. K., Ma, O. C. K., Lauder, I. J., Ng, C. P. L., & Chung, H.-T. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90337-x · Cited by 242
Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection
Lok, A. S. F., & Lai, C.-L. (1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90069-4 · Cited by 238
Lau, G. K. K., Leung, Y.-H., Fong, D. Y. T., Au, W.-Y., Kwong, Y.-L., Lie, A., Hou, J.-L., Wen, Y.-M., Nanj, A., & Liang, R. (2002) · Blood · doi:10.1182/blood.v99.7.2324 · Cited by 233
Natural history of chronic hepatitis B in co-infected patients
Puoti, M., Torti, C., Bruno, R., Filice, G., & Carosi, G. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.015 · Cited by 224
Mason, A. L., Xu, L., Guo, L., Kuhns, M., & Perrillo, R. P. (1998) · Hepatology · doi:10.1002/hep.510270638 · Cited by 208
Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy
Westhoff, T. H., Jochimsen, F., Schmittel, A. H., Stöffler-Meilicke, M., Schäfer, J.-H., Zidek, W., Gerlich, W. H., & THIEL, E. (2003) · Blood · doi:10.1182/blood-2003-05-1403 · Cited by 203
Lau, G. K. K., Suri, D., Liang, R., Rigopoulou, E. I., Thomas, M. G., Mullerova, I., Nanji, A., Yuen, S., Williams, R., & Naoumov, N. V. (2002) · Gastroenterology · doi:10.1053/gast.2002.31887 · Cited by 179
Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy
Yeo, W., Lam, K. C., Zee, B., Chan, P. S. K., Mo, F. K. F., Ho, W. M., Wong, W. L., Leung, T. W. T., Chan, A. T. C., Ma, B., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh430 · Cited by 177
Dh??din, N., Douvin, C., Kuentz, M., Saint Marc, M. F., Reman, O., Rieux, C., Bernaudin, F., Norol, F., Cordonnier, C., Bobin, D., et al. (1998) · Transplantation · doi:10.1097/00007890-199809150-00012 · Cited by 174
Liang, R. H. S., Lau, G. K. K., & Kwong, Y. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.394 · Cited by 171
Onozawa, M., Hashino, S., Izumiyama, K., Kahata, K., Chuma, M., Mori, A., Kondo, T., Toyoshima, N., Ota, S., Kobayashi, S., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000151661.52601.fb · Cited by 160
Hepatitis B infection in patients with lymphomas
Liang, R. H. S., Lok, A. S.-F., Lai, C., Chan, T. K., Todd, D., & Chiu, E. (1990) · Hematological Oncology · doi:10.1002/hon.2900080504 · Cited by 130
Vento, S., Cainelli, F., & Longhi, M. S. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00773-8 · Cited by 125
Hepatitis Viruses and Hematopoietic Cell Transplantation: A Guide to Patient and Donor Management
Strasser, S. I., & McDonald, G. B. (1999) · Blood · doi:10.1182/blood.v93.4.1127 · Cited by 122
Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy
Yeo, W., Steinberg, J., Tam, J. S., Chan, P. K. S., Leung, N. W. Y., Lam, K. C., Mok, T. S. K., & Johnson, P. J. (1999) · Journal of Medical Virology · Cited by 107
Lamivudine Therapy for Chemotherapy-Induced Reactivation of Hepatitis B Virus Infection
Ahmed, A., & Keeffe, E. B. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00689-3 · Cited by 95
Liao, C., Lee, C., Wu, H., Wang, M., Lu, S., & Eng, H. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03239.x · Cited by 89
Chronic Hepatitis B: Current Testing Strategies
Gish, R. G., & LOCARNINI, S. A. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.017 · Cited by 67
Yu, A. S., Cheung, R. C., & Keeffe, E. B. (2006) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2006.01.004 · Cited by 63
Ilan, Y., Nagler, A., Zeira, E., Adler, R., Slavin, S., & Shouval, D. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702571 · Cited by 52
Self-citationHsiao, L., Chiou, T.-J., Liu, H., Chu, C.-J., Lin, Y., Chao, T., Wang, W.-S., Yen, C., Yang, M., Tzeng, C., et al. (2006) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2005.09.001 · Cited by 49
Vassiliadis, T. G., Garipidou, V., Τζιόμαλος, Κ., Perifanis, V., Γιουλεμέ, Ό., & Vakalopoulou, S. (2005) · American Journal of Hematology · doi:10.1002/ajh.20471 · Cited by 45
Hui, C., Bowden, S., Jackson, K., Au, W., Fong, D., Lie, A. K. W., Chim, C. S., Liang, R. H. S., & Lau, G. K. K. (2005) · Blood · doi:10.1182/blood-2004-09-3402 · Cited by 41
Cortelezzi, A., Viganò, M., Zilioli, V. R., Fantini, N. N., Pasquini, M. C., DELILIERS, G., Colombo, M., & Lampertico, P. (2005) · Journal of Clinical Virology · doi:10.1016/j.jcv.2005.10.009 · Cited by 38
Update on viral hepatitis: 2006
Tan, J. Y.-L., & Lok, A. S.-F. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328049ddc1 · Cited by 34
Hepatitis B virus genotypes, core gene variability and ethnicity in the Pacific region
Jazayeri, M. S., Basuni, A. A., Cooksley, G., LOCARNINI, S. A., & Carman, W. F. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.03.025 · Cited by 33
Hepatitis B virus infection and bone marrow transplantation
Lau, G. K. K., Lee, C. K., & Liang, R. H. S. (1999) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(98)00042-0 · Cited by 27
Hepatitis B immunisation in Britain: time to change?
Banatvala, J. E. (2006) · BMJ · doi:10.1136/bmj.332.7545.804 · Cited by 23
Update on viral hepatitis: 2005
Wong, S. N., & Lok, A. S.-F. (2006) · Current Opinion in Internal Medicine · doi:10.1097/01.mog.0000218960.48064.f2 · Cited by 16
Bonkovsky, H. L., Jones, D. P., LaBrecque, D. R., & Shedlofsky, S. I. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50031-0 · Cited by 15
Cited by
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
European Association for the Study of the Liver (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.010 · Cited by 2,925
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
Sarin, S. K., Kumar, M., Lau, G. K., Abbas, Z., Chan, H. L. Y., Chen, C. J., Chen, D. S., Chen, H. L., Chen, P. J., Chien, R. N., et al. (2016) · Hepatology International · doi:10.1007/s12072-015-9675-4 · Cited by 2,550
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.001 · Cited by 1,347
Dienstag, J. L. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801644 · Cited by 961
Statements from the Taormina expert meeting on occult hepatitis B virus infection
Raimondo, G., Allain, J.-P., Brunetto, M. R., Buendia, M.-A., Chen, D.-S., Colombo, M., Craxì, A., Donato, F., Ferrari, C., Gaeta, G. B., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.014 · Cited by 833
Self-citation
Metadata
- Authors
- Lalazar, G., Rund, D., & Shouval, D.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2007-01-08
- Volume
- 136
- Issue
- 5
- Pages
- 699-712
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2119526388
- Cited by
- 311
- References
- 55
- FWCI
- 20.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.